A detailed history of Wedgewood Investors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wedgewood Investors Inc holds 942 shares of LLY stock, worth $723,229. This represents 0.93% of its overall portfolio holdings.

Number of Shares
942
Previous 899 4.78%
Holding current value
$723,229
Previous $813,000 2.58%
% of portfolio
0.93%
Previous 0.98%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $33,202 - $41,280
43 Added 4.78%
942 $834,000
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $26,259 - $30,956
50 Added 5.89%
899 $524,000
Q4 2022

Jan 25, 2023

BUY
$321.55 - $374.67 $272,995 - $318,094
849 New
849 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wedgewood Investors Inc Portfolio

Follow Wedgewood Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedgewood Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Wedgewood Investors Inc with notifications on news.